{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:16:12Z","timestamp":1793333772197,"version":"4.5.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"Importance<\/jats:title>Subacute thyroiditis (SAT) is a self-limiting and inflammatory thyroid disease. Although SAT usually improves on its own within weeks, it needs treatment when patients have pain, fever, and symptoms of thyrotoxicosis. Therapeutic drugs mainly include non-steroidal anti-inflammatory drugs (NSAIDs) and glucocorticoids. Currently, there is no systematic review or meta-analysis of the comparison of outcomes between NSAIDs and glucocorticoids for the treatment of SAT.<\/jats:p><\/jats:sec>Objectives<\/jats:title>To conduct a systematic review and meta-analysis on the outcomes in subacute thyroiditis patients treated with glucocorticoids or NSAIDs.<\/jats:p><\/jats:sec>Data sources<\/jats:title>Using the four electronic databases, including PubMed, Embase, Cochrane Library, Wanfang database and Web of Science. All publications until 21 June 2023 were searched. The reference lists of all selected articles were independently screened to identify additional studies left out in the initial search.<\/jats:p><\/jats:sec>Study selection<\/jats:title>The literature comparing outcomes between glucocorticoids and non-steroidal anti-inflammatory drugs for patients with subacute thyroiditis will be included.<\/jats:p><\/jats:sec>Data extraction and synthesis<\/jats:title>Two independent investigators (Anqi Yuan and Jialu Wu) extracted the data following Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines (PRISMA) and then evaluated the quality of the eligible studies with the Newcastle-Ottawa Scale. Fixed-effects models for the meta-analyses were applied. Heterogeneity was assessed with the chi-squared (x\u00b2) test (Cochran\u2019s Q) and inconsistency index (I\u00b2). The robustness of the results was tested with the sensitivity analyses. The bias of publication was assessed with the Harbord test.<\/jats:p><\/jats:sec>Main outcomes and measures<\/jats:title>The incidence of permanent hypothyroidism in SAT patients treated with corticosteroids or NSAIDs.<\/jats:p><\/jats:sec>Results<\/jats:title>Our study included a total of ten comparative cohort studies with 1337 participants. We found that the incidence of developing permanent hypothyroidism in the SAT patients who received glucocorticoids treatment was significantly lower than those who received NSAIDs treatment. (OR, 0.56; 95% CI, 0.36\u20130.88; P = 0.01). The risk of permanent hypothyroidism in patients who received prednisone at an average initial dose &lt; 40 mg\/d was significantly lower than that in patients who received NSAIDs (OR, 0.37; 95% CI, 0.14\u20130.94; P = 0.04). There was no significant difference in the occurrence of permanent hypothyroidism between SAT patients who received an average initial dose \u2265 40 mg\/d of prednisone and those who received only NSAIDs (OR, 0.7; 95% CI, 0.14\u20133.53; P = 0.67). In addition, the recurrence rate was observably higher in those receiving glucocorticoids than in those receiving NSAIDs (OR, 1.98; 95% CI, 1.12\u20133.5; p = 0.02). The recurrence rate was significantly higher in patients with an average initial prednisone dose of &lt; 40 mg\/d than in the NSAIDs group. There was no significant difference in the recurrence rate between patients in the mean initial prednisone dose \u2265 40 mg\/d group and those in the NSAIDs group.<\/jats:p><\/jats:sec>Conclusions and relevance<\/jats:title>In this meta-analysis, we compared the treatment outcomes of SAT patients between glucocorticoids and NSAIDs. Our results indicated that glucocorticoid treatment was associated with a lower incidence of permanent hypothyroidism than NSAID treatment. Patients treated with NSAIDs might have a lower recurrence rate. This finding might help to understand the outcome of the disease when choosing different drugs and help physicians to make appropriate decisions.<\/jats:p><\/jats:sec>Systematic review registration<\/jats:title>https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:uri>, identifier CRD42023427332.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1384365","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T10:59:08Z","timestamp":1713869948000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of treatment outcome between glucocorticoids and non-steroidal anti-inflammatory drugs in subacute thyroiditis patients\u2014a systematic review and meta-analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Anqi","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(23)00005-0","article-title":"Hyperthyroidism: etiology, pathogenesis, diagnosis, management, complications, and prognosis","volume":"11","author":"Wiersinga","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1126637","article-title":"Subacute thyroiditis following COVID-19: A systematic review","volume":"14","author":"Meftah","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2012.01.003","article-title":"Subacute, silent, and postpartum thyroiditis","volume":"96","author":"Samuels","year":"2012","journal-title":"Med Clin North Am"},{"key":"B4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1089\/thy.2010.0417","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists","volume":"21","author":"Bahn Chair","year":"2011","journal-title":"Thyroid"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1743-422X-6-5","article-title":"Viruses and thyroiditis: an update","volume":"6","author":"Desailloud","year":"2009","journal-title":"Virol J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"dgaa276","DOI":"10.1210\/clinem\/dgaa276","article-title":"Subacute thyroiditis after sars-COV-2 infection","volume":"105","author":"Brancatella","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-021-09648-y","article-title":"New aspects in the pathogenesis and management of subacute thyroiditis","volume":"22","author":"Stasiak","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.47.0740","article-title":"Clinical characteristics of 852 patients with subacute thyroiditis before treatment","volume":"47","author":"Nishihara","year":"2008","journal-title":"Intern Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-45-2-270","article-title":"Subacute (de Quervain\u2019s) thyroiditis: association with HLA-Bw35 antigen and abnormalities of the complement system, immunoglobulins and other serum proteins","volume":"45","author":"Nyulassy","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.80.12.8530615","article-title":"Clinical characteristics of subacute thyroiditis classified according to human leukocyte antigen typing","volume":"80","author":"Ohsako","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.251504","article-title":"The role of nuclear medicine in the clinical management of benign thyroid disorders, part 2: nodular goiter, hypothyroidism, and subacute thyroiditis","volume":"62","author":"Mariani","year":"2021","journal-title":"J Nucl Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2009.07.004","article-title":"Interferon induced thyroiditis","volume":"23","author":"Tomer","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/BF03346347","article-title":"Demographic and clinical features of patients with subacute thyroiditis: results of 169 patients from a single university center in Turkey","volume":"30","author":"Erdem","year":"2007","journal-title":"J Endocrinol Invest"},{"key":"B14","doi-asserted-by":"publisher","first-page":"794943","DOI":"10.1155\/2014\/794943","article-title":"Subacute thyroiditis: clinical presentation and long term outcome","volume":"2014","author":"Alfadda","year":"2014","journal-title":"Int J Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021799","article-title":"Clinical features and outcome of subacute thyroiditis in an incidence cohort: olmsted county, minnesota, study","volume":"88","author":"Fatourechi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229","article-title":"American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3413\/Nukmed-0536-12-10","article-title":"Thyroiditis de Quervain. Are there predictive factors for long-term hormone-replacement","volume":"52","author":"Schenke","year":"2013","journal-title":"Nuklearmedizin"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1055\/a-0998-8035","article-title":"Long-term outcome of subacute thyroiditis","volume":"128","author":"G\u00f6rges","year":"2020","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1159\/000513745","article-title":"Two important issues in subacute thyroiditis management: delayed diagnosis and inappropriate use of antibiotics","volume":"10","author":"Bostan","year":"2021","journal-title":"Eur Thyroid J"},{"key":"B20","article-title":"Thyroiditis: evaluation and treatment","volume":"104","author":"Martinez Quintero","year":"2021","journal-title":"Am Fam Physician"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-1122-3","article-title":"Comparison of the therapeutic effects of prednisolone and nonsteroidal anti-inflammatory drugs in patients with subacute thyroiditis","volume":"55","author":"Sato","year":"2017","journal-title":"Endocrine"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A2017","article-title":"Subacute thyroiditis presenting as a focal lesion on [18F] fluorodeoxyglucose whole-body positron-emission tomography\/CT","volume":"32","author":"Yeo","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"9388","DOI":"10.3390\/ijerph19159388","article-title":"Subacute thyroiditis-still a diagnostic challenge: data from an observational study","volume":"19","author":"Zornitzki","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/BF03347442","article-title":"Subacute thyroiditis: Clinical characteristics and treatment outcome in fifty-six consecutive patients diagnosed between 1999 and 2005","volume":"30","author":"Benbassat","year":"2007","journal-title":"J Endocrinol Invest"},{"key":"B25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.21037\/atm","article-title":"Initial treatment combined with Prunella vulgaris reduced prednisolone consumption for patients with subacute thyroiditis","volume":"7","author":"Li","year":"2019","journal-title":"Ann Transl Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.40.292","article-title":"Evaluation of recurrence in 36 subacute thyroiditis patients managed with prednisolone","volume":"40","author":"Mizukoshi","year":"2001","journal-title":"Internal Med (Tokyo Japan)"},{"key":"B27","unstructured":"2023"},{"key":"B28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2288-14-45","article-title":"Newcastle-Ottawa Scale: comparing reviewers\u2019 to authors\u2019 assessments","volume":"14","author":"Lo","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"16899","DOI":"10.1038\/s41598-019-53475-w","article-title":"An evaluation of the results of the steroid and non-steroidal anti-inflammatory drug treatments in subacute thyroiditis in relation to persistent hypothyroidism and recurrence","volume":"9","author":"Sencar","year":"2019","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4183\/aeb.2022.64","article-title":"The use of low dose prednisolone in patients with subacute thyroiditis and its effect on impaired life and sleep quality","volume":"18","author":"Saydam","year":"2022","journal-title":"Acta Endocrinol (Buchar)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2017.119","article-title":"Is there a drug effect on the development of permanent hypothyroidism in subacute thyroiditis","volume":"13","author":"Saklamaz","year":"2017","journal-title":"Acta Endo (Buc)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345675","article-title":"Extent of hypoechogenic area in the thyroid is related with thyroid dysfunction after subacute thyroiditis","volume":"32","author":"Nishihara","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00047\/full","article-title":"Two-years prospective follow-up study of subacute thyroiditis","volume":"47","author":"Zhao","year":"2020","journal-title":"Front Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000473","article-title":"Factors affecting recurrence in subacute granulomatous thyroiditis","volume":"66","author":"Bahadir","year":"2022","journal-title":"Arch Endocrinol Metab"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2020.09.001","article-title":"Thyroid disorders and SARS-CoV-2 infection: From pathophysiological mechanism to patient management","volume":"81","author":"Caron","year":"2020","journal-title":"Ann Endocrinol (Paris)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1055\/s-0029-1210522","article-title":"Late hypothyroidism following subacute thyroiditis","volume":"87","author":"Gozariu","year":"1986","journal-title":"Exp Clin Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1530\/EC-21-0212","article-title":"C-reactive protein and thyroid-stimulating hormone levels as risk factors for hypothyroidism in patients with subacute thyroiditis","volume":"10","author":"Tang","year":"2021","journal-title":"Endocr Connect"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K07E-163","article-title":"Association of the ultrasonographic findings of subacute thyroiditis with thyroid pain and laboratory findings","volume":"55","author":"Omori","year":"2008","journal-title":"Endocr J"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.783439\/full","article-title":"Risk factors for subacute thyroiditis recurrence: A systematic review and meta-analysis of cohort studies","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Endocrinol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.eprac.2020.11.009","article-title":"The evaluation of low- and high-dose steroid treatments in subacute thyroiditis: A retrospective observational study","volume":"27","author":"Hepsen","year":"2021","journal-title":"Endocr Pract"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3390\/ijms20051089","article-title":"The risk of recurrence of subacute thyroiditis is HLA-dependent","volume":"20","author":"Stasiak","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2174\/2772432816666211012092112","article-title":"Identifying the lowest effective initial dose of prednisolone for the treatment of subacute granulomatous thyroiditis: A systematic review and meta-analysis","volume":"17","author":"Soltani","year":"2022","journal-title":"Curr Rev Clin Exp Pharmacol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.7888\/juoeh.37.103","article-title":"Prednisolone dosing regimen for treatment of subacute thyroiditis","volume":"37","author":"Arao","year":"2015","journal-title":"J UOEH"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2015\/14893.6427","article-title":"Treatment of Acute Painful Thyroiditis with Low Dose Prednisolone: A Study on Patients from Western Nepal","volume":"9","author":"Koirala","year":"2015","journal-title":"J Clin Diagn Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1384365\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T10:59:11Z","timestamp":1713869951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1384365\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":44,"alternative-id":["10.3389\/fendo.2024.1384365"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1384365","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,23]]},"article-number":"1384365"}}